Prudential Financial Inc. raised its position in shares of Teladoc Inc. (NYSE:TDOC) by 56.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 301,700 shares of the company’s stock after buying an additional 108,900 shares during the period. Prudential Financial Inc. owned 0.66% of Teladoc worth $4,834,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of TDOC. CWM LLC raised its position in shares of Teladoc by 171.7% in the second quarter. CWM LLC now owns 371,358 shares of the company’s stock valued at $5,949,000 after buying an additional 234,678 shares during the last quarter. Tiverton Asset Management LLC raised its position in shares of Teladoc by 145.7% in the first quarter. Tiverton Asset Management LLC now owns 368,477 shares of the company’s stock valued at $3,537,000 after buying an additional 218,477 shares during the last quarter. P.A.W. Capital Corp purchased a new position in shares of Teladoc during the second quarter valued at approximately $1,762,000. State Street Corp raised its position in shares of Teladoc by 54.0% in the first quarter. State Street Corp now owns 186,784 shares of the company’s stock valued at $1,795,000 after buying an additional 65,519 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. purchased a new position in shares of Teladoc during the first quarter valued at approximately $479,000. Hedge funds and other institutional investors own 40.45% of the company’s stock.
Shares of Teladoc Inc. (NYSE:TDOC) opened at 15.77 on Friday. The company’s market cap is $720.77 million. The firm’s 50-day moving average price is $17.97 and its 200 day moving average price is $14.66. Teladoc Inc. has a 52 week low of $9.08 and a 52 week high of $22.00.
Teladoc (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.39) by $0.01. Teladoc had a negative return on equity of 33.97% and a negative net margin of 60.88%. The business earned $26.50 million during the quarter, compared to analysts’ expectations of $28.20 million. During the same quarter in the previous year, the firm earned ($0.46) EPS. The firm’s revenue was up 44.9% compared to the same quarter last year. On average, equities analysts predict that Teladoc Inc. will post ($1.45) EPS for the current fiscal year.
Several brokerages have recently commented on TDOC. Deutsche Bank AG decreased their target price on Teladoc from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, August 4th. FBR & Co decreased their target price on Teladoc from $34.00 to $28.00 and set an “outperform” rating for the company in a research report on Thursday, August 4th. Oppenheimer Holdings Inc. reiterated an “outperform” rating and issued a $24.00 target price (down previously from $25.00) on shares of Teladoc in a research report on Friday, August 5th. Zacks Investment Research lowered Teladoc from a “hold” rating to a “sell” rating in a research report on Tuesday, September 20th. Finally, Piper Jaffray Cos. reiterated an “overweight” rating and issued a $21.00 target price (down previously from $22.00) on shares of Teladoc in a research report on Friday, August 5th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $22.90.
In related news, insider Adam C. Vandervoort sold 52,865 shares of the business’s stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $16.64, for a total transaction of $879,673.60. Following the transaction, the insider now directly owns 46,685 shares in the company, valued at $776,838.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director James K. Outland sold 10,000 shares of the business’s stock in a transaction dated Tuesday, August 2nd. The shares were sold at an average price of $18.00, for a total value of $180,000.00. Following the transaction, the director now owns 49,089 shares in the company, valued at $883,602. The disclosure for this sale can be found here. Corporate insiders own 5.94% of the company’s stock.
Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc. (NYSE:TDOC).
Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.